PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer
Article in Molecular Cancer Therapeutics (May 2024)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Molecular Cancer Therapeutics (May 2024)